What's the prospect of being a biochemical reagent, that is, a biochemical reagent?

Global biological research reagent enterprises grow rapidly through mergers and acquisitions

The market share of foreign biochemical reagent is mainly occupied by the United States, Germany, Japan and other countries, which started early, attached importance to research and development, advanced technology and strong global awareness, and most of the experiments in internationally renowned scientific magazines such as Science》《Nature used the products of these three countries. There are many kinds and complete varieties of biochemical reagent products abroad, and there are at least 1, kinds of biochemical reagent currently supplied. In addition to paying attention to the specificity and accuracy of products, foreign companies have also increased their research and development efforts, and cooperated with world-renowned universities and famous research institutes to update thousands of new reagents every year. In order to better ensure the quality of biochemical reagent, well-known foreign biological companies will establish strict quality and quality inspection standards, and attach great importance to production technology and sanitary environment, and generally adopt computer-aided production and technology development.

in the early stage of development, small and medium-sized family businesses prevailed in the biological research reagent industry in developed countries such as Europe and America, and the industry concentration was low. In order to pursue higher profits, biochemical reagent companies take joint and merger measures to supplement their needs, enhance their overall strength and seize the international market. Since 198s, the biological research reagent industry in Europe and America has entered the period of industrial integration, with frequent mergers and acquisitions. A large number of biological research reagent enterprises such as German Merck KgaA, Thermo-Fisher Scientific, Danaher and Avantor have achieved rapid growth through continuous integration. For example, after the merger of Thermo Electron (founded in 1956) and Fisher Scientific (founded in 192) in 26, * * * conducted dozens of commercial mergers and acquisitions, with rapid growth in performance and steady increase in market share. Other manufacturers in the industry also carried out continuous mergers and acquisitions, and the industry concentration was significantly improved.

foreign manufacturers occupy 9% of China market

Frost &; According to Sullivan's statistics, in the user market of scientific research institutions, foreign brands occupy a dominant position by virtue of the advantages accumulated over the years, and foreign brands such as Thermo Fisher Scientific, Candace Flynn, Andy Bio and Bao Bio account for 9% of the market. Among them, Thermo Fisher Scientific has the highest market share, accounting for 9.3%, followed by Candace Flynn and Andy Bio, with market shares of 3.2% and 2.3% respectively. Domestic manufacturers Novozen, Yisheng Bio and Yiqiao Shenzhou are among the top brands in China, accounting for 2.42%, 1.21% and .71% respectively.

competition pattern of global molecular biological research reagent enterprises

In recent years, the global molecular biological research reagent has developed rapidly. At present, in developed countries or regions such as the United States and Europe, the molecular biological research reagent industry has basically developed and the market competition pattern is relatively stable. Leading enterprises in the industry have developed on a large scale through acquisitions, and the concentration of the industry is on the rise, and a number of multinational enterprises with world influence have been born.

The global representative enterprises of molecular biological research reagents are mainly global scientific service providers such as Thermo Fisher Scientific, Candace Flynn, Takara and BioRad.

competition pattern of global protein biological scientific research reagent enterprises

The global market of protein scientific research reagents is highly dispersed, mainly because the demand for protein expression and proteomics analysis services is relatively low compared with other life science services. With the development of synthetic biology, its demand in the global research protein and antibody related services and products market is expected to continue to grow.

R&, a subsidiary of p>Bio-Techne; D Systems' recombinant protein products are rich and stable in quality, enjoying a good reputation in the industry, and it is one of the world leaders in immunology and cell biology products. In recent years, with the development of China's biotechnology industry and technological progress, domestic biochemical reagent manufacturers have gradually embarked on the road of exploring the global market, and some domestic manufacturers, including Yiqiao Technology, regard overseas markets as the focus of market development.

Competition pattern of global cell-based biological research reagent enterprises

Cell-based biological research reagents occupy about half of the global market share of biological research reagents, and the biological research reagent industries represented by Thermo Fisher Scientific, Danaher and merck kgaa have also made great achievements in the field of cell-based biological research reagents. At present, the global competition pattern of cellular biological research reagents is similar to that of biological research reagents industry, with high market concentration and monopoly competition as the main form of competition.

The competition pattern of cellular biological research reagents in China is similar to that of biological research reagents industry. Because the industry started late, there is a certain gap between industrial enterprises and overseas multinational enterprises, and the industry market is still mainly occupied by imported products. According to the echelon, the first echelon enterprises in China's cell biological research reagent industry are well-known overseas manufacturers represented by Thermo Fisher Scientific and Danaher; The second echelon is the local leading enterprises represented by Aladdin and Unionway. The third echelon is other industrial enterprises with small market share and unable to form a certain scale benefit. For more research and analysis of this industry, please refer to Foresight Industry Research Institute's Analysis Report on Development Prospect Forecast and Investment Strategic Planning of Biomedical Industry in China.